Exchange: NASDAQ·Updated 01:30 PM EST
IMNN logo

IMNN Imunon Inc

$0.8801
$0.0269
(2.97%)
Today
Mkt Cap$5.09M
Vol59,573.00

About IMNN

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
50

Neutral Sentiment

How do you feel about IMNN?

steplondon
$IMNN so they only sold ThermoDox for glioblastoma and not the IMNN-001 for ovarian cancer, correct?
1
3
ALSCellTherapy
$IMNN Wow dropped below a $1 again after a recent 1 for 15 reverse stock split. And the market cap is $5M. What a s*** show! Unless MANAGEMENT has a partnership or buyout already inked they are a complete and colossal failure of epic proportions!!! If MANAGEMENT does another reverse stock split when the outstanding shares are only 6 million they should be immediately canned and fired! They should delist to OTC if this happens. They have already devastated and hurt shareholders enough with the previous reverse stock split.
6
bxp2390
$IMNN May all have to agree with jegglie's characterization of management, he's been right all along here.
5
ALSCellTherapy
$IMNN No partnership talks ever existed. Dr. Lindborg and management lied. Yet another highly dilutive offering. Completely screwing their shareholders again.
5
ConcernedCitizen23
$IMNN I hope you guys connected the dots from release yesterday. The glioblastoma piece is part of the Imunon National cancer institute collaboration so that’s going to be a free trial with no expenses. I wonder how many more spinoffs like that are possible?!?
5
bxp2390
$IMNN The only financing path forward - outside of an outright sale, which is the second most sensible thing to pursue - is to give up global non-US rights to an international pharma for some amount that can fund another year or two of trials. It may seem like a steep price for complete rights if the trial succeeds, but desperate times call for desperate measures. I've spent a lot of time uploading papers and other information to some of the smarter AI tools and there is a small chance that the trial does succeed despite what all the bears note here because there is a differentiated mechanism here unlike prior IL-12 attemps at gene therapy. 11:17 AM
5
ConcernedCitizen23
$IMNN I’ve said this before and have obviously been proven wrong but I think we’re getting to the point that even the super stubborn ceo and chairman will HAVE to finally sell to stop the bleeding. Their runway is coming to an end.
5
jjegglie
$IMNN I owe everyone here an apology. To friends and enemies both. I get very emotional about this company and sometimes take a tone that is less than constructive. That emotion has never once been about money lost. I've made hundreds of losing trades. No, make no mistake, my feelings come from the absolute reprobates that run this company and their disregard for everything but keeping themselves paid. Because not enough people think about how their actions hurt people. They openly steal money from investors, without a hint of regret. But far worse than that, they kill sick people with fake medicines which they already know don't work. Butter coated doxorubicin, AKA Thermodox.....yes, that Thermodox failed in the clinic the first time nearly 14 years ago. Then again in 2020, for the exact same indication. And multiple other times when it didn't even clear phase 1. And now they use it again to pump the stock clearing the way for a 400% dilution. Cont......
1
1
ConcernedCitizen23
$IMNN they have announced that they’re recruiting 0.5 patients /phase 3 site/month and had 27 patients a few months ago. I bet they’re at 50+ at this point. Not bad for a $6 mill market cap with a $16.5 mill agreement on your third line product.
4
KBernardBio
$IMNN 2020 to 2026. 99% gone. Scam is an understatement. Slow death. Allowed to scam. Not investigated. Let to scam people. Will SEC investigate them?
4
Nimrod44
$IMNN beautiful leg, increased my position here. Should be a good paycheck either end of week or upon earnings call.
3
bxp2390
$IMNN The deal announced yesterday is a free option, and any benefit the stock gets from this is due to option value. This is an asset Imunon is not currently using and was able to structure something that can only have upside and no downside. But what would really move the stock is a real deal on international rights for the main product.
3
ALSCellTherapy
$IMNN If Dr. Lindborg and team actually goes through with this they are nuts! Hopefully common sense prevails here and they pull back!
2
jjegglie
$IMNN This is the part where the hard core zealot longs typically take their balls and slink away silently.
2
jjegglie
$IMNN Odd how Sleazy Statborg issued a statement during the big asset "sale", but nothing from any "voxeldox" executives, all of whom are so low rep, they can't be found anywhere. I do see that celsion has worked to flesh out the fake website that was only registered a month ago. So a company just appeared out of nowhere, run by nobody, with no discernible financing and saved celsion shares from free falling below$1. Immaculate timing if you ask me.
2
Ferryf
$IMNN IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026.
1
STONKONAUT_TRADING
$IMNN $INO $IMNN could see a pop from INOs approval for plasmid drug also involved with plasmids per Google search…
1
bomber1
$IMNN They have a drug in Phase 3 trials, yet they can’t contain the downward pressure—what a bunch of incompetents!!! And forget about just dilution: in a month, the share price will be 50 cents... this carnage is unbelievable.
1
LabPsycho
$IMNN Pretty obvious to me well over a year ago, what kind of a 'company' this was. Too bad, the data looks promising. And there is probably a 2.5X play on this stock in the next 16 months - but from what bottom? Still working on my (free) book - The BioGrifter's Wealth Transfer Playbook. Hope to get it out to maybe help a few from losing gobs of $$$. Good luck
1
Aawilliam2003
$IMNN is it possible the stock could go to a negative number like -$5 per share. So they’d actually pay you to buy it? Might bring some buyers
1

Advertisement|Remove ads.